Wesley Yip, M.D.

Wesley Yip, M.D., has a passion for urology that stems from its blend of surgery and medicine, which allows him to address issues that significantly impact patients' daily lives. He strives to provide compassionate, patient-centered care, emphasizing thorough and honest communication. 

Dr. Yip's research interests include clinical trial design, urinary biomarkers and genomics. He also specializes in the treatment of kidney, bladder, upper tract, prostate, testis, adrenal and penile cancers. He completed his medical degree and urology residency at the University of Southern California, and then pursued advanced training through a Society of Urologic Oncology fellowship at Memorial Sloan Kettering Cancer Center. Additionally, he has authored over 30 publications, including a groundbreaking clinical trial published in the Journal of Clinical Oncology, establishing neoadjuvant chemotherapy as a standard of care for high-risk upper tract urothelial carcinoma.

Born and raised in Los Angeles, Dr. Yip has a personal connection to the community he serves. He first came to City of Hope as an undergraduate summer student in the laboratory of Steven Smith, Ph.D., with time split in the operating rooms of Clayton Lau, M.D., and Timothy Wilson, M.D.

AWARDS

• NIH T32 Ruth L. Kirschstein Institutional National Research Service Award
• MSK Bladder SPORE Developmental Research Program Award
• Conquer Cancer Merit Award
• John P. Stein Award
• Arnold Heyman Award
• Outstanding Teaching as a House Officer Award
• Journal of Urology Best Reviewer Award
• Alpha Omega Alpha National Honor Society

MEMBERSHIPS

• Society of Urologic Oncology
• American Urological Association
• American Society of Clinical Oncology
• American Medical Association
• Society for Immunotherapy of Cancer

• Douglawi A, Ghoreifi A, Carbonara U, Yip W, Uzzo RG, Margulis V, Ferro MT, de Cobelli O, Wu Z, Simone G, Mastroianni R, Rha KH, Eun DD, Reese AC, Porter JR, Derweesh IH, Mehrazin R, Rosiello G, Tellini R, Jamil ML, Kenigsberg AP, Farrow JM, Schrock WP, Cacciamani GE, Srivastava A, Bhattu AS, Mottrie A, Gonzalgo ML, Sundaram CP, Abdollah FF, Minervini A, Autorino R, Djaladat H. Impact of Variant Histology on Oncological. Outcomes in Upper Tract Urothelial Carcinoma: Results from the ROBUUST Collaborative Group. May 2023. Clinical Genitourinary Cancer.
• Yip W, Sjoberg DD, Nogueira LM, Tracey AT, Alvim RG, Reisz PA, Demac QE, Benfante NE, Wilcox Vanden Berg RN, Kim K, Al-Ahmadie H, Lin O, Bochner BH, Dalbagni G, Donat SM, Pietzak EJ, Hakimi AA, Solit DB, Scherz A, Bajorin DF, Coleman JA. Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-Targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma. May 2023. Journal of Urology 209(5): 863-871.
• Coleman JA, Yip W, Wong NC, Sjoberg DD, Bochner BH, Dalbagni G, Donat SM, Herr HW, Cha EK, Donahue TF, Pietzak EJ, Hakimi AA, Kim K, Al-Ahmadie HA, Vargas HA, Alvim RG, Ghafoor S, Benfante NE, Meraney AM, Shichman SJ, Kamradt JM, Nair SG, Baccala AA, Palyca P, Lash BW, Rizvi MA, Swanson SK, Muina AF, Apolo AB, Iyer G, Rosenberg JE, Teo MY, Bajorin DF. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients with High-Grade Upper Tract Urothelial Carcinoma. March 2023. Journal of Clinical Oncology 41(8): 1618-1625.
• Yip W#, Ghoreifi A#, Gerald TS, Lee RA, Howard JM, Asghar AM, Khanna A, Cai J, Aron M, Gill IS, Thompson RH, Uzzo RG, Margulis V, Singla N, Djaladat H. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. March 2023. European Urology Oncology. #Contributed equally.
• Yip W, Chen AB, Malekyan C, Widjaja W, Yan K, Stankey M, Sun X, Ashrafi AN, Graham JN, Dickerson SC, Eloustaz MH, Desai MM, Gill IS, Aron M, Kim MP. An Enhanced Recovery After Surgery Protocol for Robotic-Assisted Laparoscopic Nephrectomies Utilizing a Quadratus Lumborum Block. December 2022. Journal of Robotic Surgery 16(6): 1383-1389.
• Cacciamani GE, Lee RS, Sanford DI, Yip W, Cai J, Miranda G, Daneshmand S, Aron M, Djaladat H, Gill IS, Desai MM. Impact of Patient, Surgical, and Perioperative Factors on Discharge Disposition After Radical Cystectomy. October 2022. Cancers 14(21): 5288.
• Nogueira LM#, Yip W#, Assel MJ, Tracey AT, Wong NC, Alvim RG, Al-Ahmadie H, Bajorin DF, Coleman JA. Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma. October 2022. Journal of Urology 208(4): 813-820. #Contributed equally.
• Yip W, Chen AB, Basin MF, Cacciamani GE, Bhanvadia SK. The Impact of Non-Modifiable Sociodemographic Factors on Bladder Cancer Survival Outcomes After Radical Cystectomy: A Systematic Review and Cumulative Analysis of Population Cohort Studies. September 2022. Frontiers in Urology 2: 934550.
• Ashrafi AN, Yip W, Graham JN, Yu V, Titus MB, Widjaja W, Dickerson SC, Berger AK, Desai MM, Gill IS, Aron M, Kim MP. Implementation of a Multimodal Opioid-Sparing Enhanced Recovery Pathway for Robotic-Assisted Radical Prostatectomy. June 2022. Journal of Robotic Surgery 16(3): 715-721.
• Ortega DG, Ghoreifi A, Chevinsky MS, Perez LC, Ashrafi AN, Koh K, Yip W, Medina LG, Gill IS, Djaladat, H. Tips and Tricks for Robotic Retroperitoneal Lymph Node Dissection in Testicular Cancer. April 2022. Videourology 36: 3.